OR17-4 Transcon Growth Hormone In The Treatment Of Pediatric Growth Hormone Deficiency: Results Of The Phase 3 Height Trial

Ítems similars

• Efficacy and Safety of up to 2 Years of Treatment With TransCon hGH (Lonapegsomatropin) in Treatment-Naïve and Treatment-Experienced Children With Growth Hormone Deficiency
  per: Maniatis, Aristides K, et al.
  Publicat: (2021)
• SAT-LB16 Maintenance of Favorable Treatment Effect of Once-Weekly TransCon hGH for Children With Growth Hormone Deficiency: Interim Analysis From the Enlighten Long-Term Extension Trial
  per: Maniatis, Aristides K, et al.
  Publicat: (2020)
• The rationale and design of TransCon Growth Hormone for the treatment of growth hormone deficiency
  per: Sprogøe, Kennett, et al.
  Publicat: (2017)
• OR10-05 Phase 3 FliGHt Trial: Experience of Switching from Daily Growth Hormone Therapy to Once-Weekly TransCon HGH in Children with Growth Hormone Deficiency
  per: Maniatis, Aristides K, et al.
  Publicat: (2020)
• A phase 2 trial of long-acting TransCon growth hormone in adult GH deficiency
  per: Höybye, Charlotte, et al.
  Publicat: (2017)